iBio, Inc. (IBIO)
NASDAQ
1.30
-0.01 (-0.76%)
Closed
Sep 3, 2026
Day's Range
1.291.35
52 wk Range
0.77003.82
Financial Statements - IBIO - iBio, Inc.
Revenue
400.00K▲ 77.8%
Net Income
-18.37M▲ 26.2%Net Margin -4594.3%
EBITDA
-17.03M▼ 13.4%
Free Cash Flow
-15.32M▲ 18.4%
Income Statement
| Period Ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|---|
| Sales | 400K | 225K | 0 | 1.88M | 2.37M | 1.63M |
| Cost of Goods | - | - | - | 216K | 1.46M | 703K |
| Gross Profit | - | - | - | 2.16M | 909K | 935K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -18.60M | -16.63M | -29.34M | -29.69M | -31.11M | -14M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | 1M | -98K | 7K | 10.21M | 10K |
| Pre Tax Income | -18.37M | -15.44M | -29.31M | -29.51M | -23.21M | -16.44M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -18.37M | -24.90M | -65.01M | -50.39M | -23.21M | -16.44M |
| EPS Basic | -1.75 | -6.5 | -106.19 | -115.6 | -60 | -305 |
| EPS Diluted | -1.75 | -6.5 | -106.19 | -115.6 | -60 | -305 |
| Basic Shares Outstanding | 10.49M | 3.83M | 612K | 436.05K | 391.24K | 125.59K |
| Diluted Shares Outstanding | 10.49M | 3.83M | 612K | 436.05K | 391.24K | 125.59K |
| Ebit | -18.16M | -15.27M | -29.22M | -29.51M | -20.75M | -13.97M |
| Ebitda | -17.03M | -15.02M | -27.75M | -25.72M | -28.54M | -11.73M |
| Net Income Continuous Operations | -18.37M | -24.90M | -65.01M | -50.30M | -23.21M | -16.44M |
| Minority Interests | - | - | 0 | 1K | 6K | 5K |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
